Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126719971 | 12671997 | 1 | I | 20160728 | 20160822 | 20160822 | PER | US-PFIZER INC-2016368294 | PFIZER | 0.00 | F | Y | 0.00000 | 20160822 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126719971 | 12671997 | 1 | PS | DAYPRO | OXAPROZIN | 1 | UNK | U | 18841 | TABLET | |||||||||
126719971 | 12671997 | 2 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 10 MG, UNK | U | 20702 | 10 | MG | FILM-COATED TABLET | |||||||
126719971 | 12671997 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
126719971 | 12671997 | 4 | SS | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 2 MG, UNK | U | 0 | 2 | MG | ||||||||
126719971 | 12671997 | 5 | SS | LISINOPRIL. | LISINOPRIL | 1 | 40 MG, UNK | U | 0 | 40 | MG | TABLET | |||||||
126719971 | 12671997 | 6 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, UNK | U | 0 | 25 | MG | TABLET | |||||||
126719971 | 12671997 | 7 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | U | 0 |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126719971 | 12671997 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |